Guifang Lu
- Co-authors
- Mudan RenShuixiang HeYarui LiDan GuoXinlan LuYan ZhaoDan ZhangYifei Chen
- Topics
- Cancer-related molecular mechanisms research (8 papers)MicroRNA in disease regulation (4 papers)RNA modifications and cancer (4 papers)
- Journals
- The FASEB JournalBiochemical and Biophysical Research CommunicationsBioMed Research International
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Guifang Lu
22 papers receiving 590 citations
Peers
Comparison fields: 5 of 72
- Molecular Biology 405
- Cancer Research 325
- Surgery 83
- Pulmonary and Respiratory Medicine 67
- Oncology 46
Countries citing papers authored by Guifang Lu
This map shows the geographic impact of Guifang Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guifang Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guifang Lu more than expected).
Fields of papers citing papers by Guifang Lu
This network shows the impact of papers produced by Guifang Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guifang Lu. The network helps show where Guifang Lu may publish in the future.
Co-authorship network of co-authors of Guifang Lu
This figure shows the co-authorship network connecting the top 25 collaborators of Guifang Lu. A scholar is included among the top collaborators of Guifang Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guifang Lu. Guifang Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 4 | |
| 4 | 51 | |
| 5 | 14 | |
| 6 | 15 | |
| 7 | 9 | |
| 8 | 28 | |
| 9 | 33 | |
| 10 | [Histone deacetylase 3 inhibitor alleviates alcohol-induced disruption of intestinal epithelial barrier via inhibiting nuclear factor κB]. | 1 |
| 11 | 68 | |
| 12 | 109 | |
| 13 | 41 | |
| 14 | 4 | |
| 15 | 12 | |
| 16 | 14 | |
| 17 | 31 | |
| 18 | 33 | |
| 19 | 19 | |
| 20 | Effect of intensive insulin therapy on prognosis and serum inflammatory cytokine levels in patients with sepsis | 1 |
About Guifang Lu
Guifang Lu is a scholar working on Cancer Research, Gastroenterology and Endocrine and Autonomic Systems, having authored 23 papers that have together received 595 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (8 papers), MicroRNA in disease regulation (4 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Cancer Research (325 citations), Toxicology (25 citations) and Molecular Biology (405 citations). Guifang Lu has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Mudan Ren, Shuixiang He, Yarui Li, Dan Guo, Xinlan Lu, Yan Zhao, Dan Zhang, Yifei Chen, Juan Zhang and Yun Wang. Their work appears in journals such as The FASEB Journal, Biochemical and Biophysical Research Communications and BioMed Research International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.